Rebecca Pendergrass Cook, MD

Tags: breast cancer immunotherapy, burkitt lymphoma, cloves syndrome, kasabach merritt phenomenon (kmp), thrombotic thrombocytopenic purpura, venous occlusive crisis, diffuse intrinsic pontine glioma (dipg), glucose 6 phosphate dehydrogenase deficiency, hereditary spherocytosis, histiocytosis, alveolar soft part sarcoma, bone sarcoma, cancer survivor, fibrosarcoma of the head & neck, giant cell tumor of the bone, musculoskeletal tumor, optic pathway glioma, pulmonary metastases, sacrococcygeal teratoma, tectal glioma, head and neck tumors, adverse effects to anticoagulants, anemia, anemia of chronic disease, antithrombin deficiency, aplastic anemia, b12 deficiency anemia, blood cancer, blood disorders, bone marrow disorders, cooley anemia, bleeding disorder, familial aplastic anemia, hemolytic anemia, hemophilia, heparin induced thrombocytopenia, idiopathic thrombocytopenic purpura, iron deficiency anemia, langerhans cell histiocytosis, leukopenia, lymphopenia, myeloproliferative diseases, neutropenia, paroxysmal nocturnal hemoglobinuria, petechiae, polycythemia, pure red cell aplasia, purpura, rh incompatibility, secondary polycythemia, sickle cell disease, splenomegaly, thalassemia, thrombocytopenia, thrombocytosis, thrombophilia, von willebrand disease, pancytopenia, acute myelogenous leukemia (aml), hemolytic uremic syndrome, lymphoma, non hodgkin lymphoma, diamond blackfan anemia, dyskeratosis congenita, factor eight disorder, factor nine deficiency, pleomorphic xanthoastrocytomas, pediatric cancer, blood clotting disorder, factor v leiden, myelodysplastic syndrome, adjuvant chemotherapy, biological targeted therapy, cancer chemotherapy, cancer genomics, chemoradiation, early detection of cancer, epithelioid hemangioendothelioma, cancer immunotherapy, li fraumeni syndrome, acute lymphoblastic leukemia (all), fanconi anemia, hemolytic disease of the fetus, hypercoagulable state, leukemia, pernicious anemia, severe congenital neutropenia, hemoglobinopathies, splenic sequestration